NCT02496546View on ClinicalTrials.gov

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Atopic Dermatitis
Interventions
DRUG

LEO 32731 cream

Applied for 3 weeks

DRUG

LEO 32731 cream vehicle

Applied for 3 weeks

Trial Locations (1)

48159

Proinnovera GmbH, Center of Dermatology Excellence, Münster

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY